15
Apr
Apr
Among the growing demand for GLP-1 drugs used to treat diabetes and weight loss support, the American Food and Drug Agency (FDA) has issued a urgent warning for consumers with OZEMPIC. The agency calls users for thorough control of drug label after discovering that hundreds of counterfeit injections Ozmpic have introduced circulation outside the authorized […]